UNSPSC 85813502: Introduction of insulin into subcutaneous tissue, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of insulin into subcutaneous tissue, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E013VG

UNSPSC 85813502 Introduction of insulin into subcutaneous tissue, percutaneous approach is a Commodity code that shows minimal relevant recent activity in state and local procurement. The code nominally describes a medical procedure, but the recent opportunities tagged to it span telehealth delivery, occupational health services, emergency medical services, wellness platforms, and specialty care—none of which align directly with insulin injection administration or subcutaneous pharmaceutical delivery. State and local health authorities, counties, and regional health systems are instead soliciting for comprehensive healthcare service delivery, behavioral health programs, EMS operations, and employee wellness platforms. The issuing bodies represent a mix of state health departments (Nevada, Texas, Colorado), county health systems (Santa Clara, DeKalb, San Mateo), regional authorities (Inland Empire Health Plan in California), and municipal entities. Geographic activity concentrates in California, Texas, Georgia, Colorado, and Nevada, with scattered solicitations across other states.

The mismatch between the code's clinical scope and the actual work being bought suggests this code may be misclassified or over-tagged in state and local systems. Recent opportunities include Inland Empire Health Plan's RFI for virtual urgent care services (California, due October 31, 2026), Nevada Health Authority's RFP for Program of All-Inclusive Care for the Elderly serving seniors with comprehensive medical and behavioral health services (due December 10, 2026), and San Mateo County's RFP for cancer registry and handheld retinal screening device services (due November 6, 2026). None of these solicitations center on insulin delivery or subcutaneous injection protocols. The code sees limited relevance to current state and local buying patterns and warrants clarification or reclassification within procurement taxonomies before pursuit.